Cargando…
Epiphora in lung cancer patients receiving docetaxel: a case series
BACKGROUND: Docetaxel is a key antineoplastic drug for treatment of non-small cell lung cancer. Ocular adverse events of docetaxel include epiphora (excess tearing) and conjunctivitis. Epiphora has been reported to be associated with canalicular and nasolacrimal duct stenosis, but it is not necessar...
Autores principales: | Yamagishi, Tomoko, Ochi, Nobuaki, Yamane, Hiromichi, Hasebe, Satoshi, Takigawa, Nagio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046091/ https://www.ncbi.nlm.nih.gov/pubmed/24886618 http://dx.doi.org/10.1186/1756-0500-7-322 |
Ejemplares similares
-
Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
por: Yamane, Hiromichi, et al.
Publicado: (2013) -
Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma
por: Ochi, Nobuaki, et al.
Publicado: (2014) -
Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study
por: Yamane, Hiromichi, et al.
Publicado: (2015) -
Acute necrotizing encephalopathy in an adult with influenza A infection
por: Ochi, Nobuaki, et al.
Publicado: (2018) -
“Engagement ring” image conveys regrettable outcome for aged patients with non‐small cell lung cancer
por: Yamane, Hiromichi, et al.
Publicado: (2018)